10Q25 and 10Q26 Deletions
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
A Multistep Bioinformatic Approach Detects Putative Regulatory
BMC Bioinformatics BioMed Central Research article Open Access A multistep bioinformatic approach detects putative regulatory elements in gene promoters Stefania Bortoluzzi1, Alessandro Coppe1, Andrea Bisognin1, Cinzia Pizzi2 and Gian Antonio Danieli*1 Address: 1Department of Biology, University of Padova – Via Bassi 58/B, 35131, Padova, Italy and 2Department of Information Engineering, University of Padova – Via Gradenigo 6/B, 35131, Padova, Italy Email: Stefania Bortoluzzi - [email protected]; Alessandro Coppe - [email protected]; Andrea Bisognin - [email protected]; Cinzia Pizzi - [email protected]; Gian Antonio Danieli* - [email protected] * Corresponding author Published: 18 May 2005 Received: 12 November 2004 Accepted: 18 May 2005 BMC Bioinformatics 2005, 6:121 doi:10.1186/1471-2105-6-121 This article is available from: http://www.biomedcentral.com/1471-2105/6/121 © 2005 Bortoluzzi et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Background: Searching for approximate patterns in large promoter sequences frequently produces an exceedingly high numbers of results. Our aim was to exploit biological knowledge for definition of a sheltered search space and of appropriate search parameters, in order to develop a method for identification of a tractable number of sequence motifs. Results: Novel software (COOP) was developed for extraction of sequence motifs, based on clustering of exact or approximate patterns according to the frequency of their overlapping occurrences. -
Construction of Stable Mouse Arti Cial Chromosome from Native Mouse
Construction of Stable Mouse Articial Chromosome from Native Mouse Chromosome 10 for Generation of Transchromosomic Mice Satoshi Abe Tottori University Kazuhisa Honma Trans Chromosomics, Inc Akane Okada Tottori University Kanako Kazuki Tottori University Hiroshi Tanaka Trans Chromosomics, Inc Takeshi Endo Trans Chromosomics, Inc Kayoko Morimoto Trans Chromosomics, Inc Takashi Moriwaki Tottori University Shusei Hamamichi Tottori University Yuji Nakayama Tottori University Teruhiko Suzuki Tokyo Metropolitan Institute of Medical Science Shoko Takehara Trans Chromosomics, Inc Mitsuo Oshimura Tottori University Yasuhiro Kazuki ( [email protected] ) Tottori University Research Article Page 1/21 Keywords: mouse articial chromosome (MAC), microcell-mediated chromosome transfer (MMCT), chromosome engineering, transchromosomic (Tc) mouse, humanized model mouse Posted Date: July 9th, 2021 DOI: https://doi.org/10.21203/rs.3.rs-675300/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 2/21 Abstract Mammalian articial chromosomes derived from native chromosomes have been applied to biomedical research and development by generating cell sources and transchromosomic (Tc) animals. Human articial chromosome (HAC) is a precedent chromosomal vector which achieved generation of valuable humanized animal models for fully human antibody production and human pharmacokinetics. While humanized Tc animals created by HAC vector have attained signicant contributions, there was a potential issue to be addressed regarding stability in mouse tissues, especially highly proliferating hematopoietic cells. Mouse articial chromosome (MAC) vectors derived from native mouse chromosome 11 demonstrated improved stability, and they were utilized for humanized Tc mouse production as a standard vector. In mouse, however, stability of MAC vector derived from native mouse chromosome other than mouse chromosome 11 remains to be evaluated. -
Bioinformatics Analyses of Genomic Imprinting
Bioinformatics Analyses of Genomic Imprinting Dissertation zur Erlangung des Grades des Doktors der Naturwissenschaften der Naturwissenschaftlich-Technischen Fakultät III Chemie, Pharmazie, Bio- und Werkstoffwissenschaften der Universität des Saarlandes von Barbara Hutter Saarbrücken 2009 Tag des Kolloquiums: 08.12.2009 Dekan: Prof. Dr.-Ing. Stefan Diebels Berichterstatter: Prof. Dr. Volkhard Helms Priv.-Doz. Dr. Martina Paulsen Vorsitz: Prof. Dr. Jörn Walter Akad. Mitarbeiter: Dr. Tihamér Geyer Table of contents Summary________________________________________________________________ I Zusammenfassung ________________________________________________________ I Acknowledgements _______________________________________________________II Abbreviations ___________________________________________________________ III Chapter 1 – Introduction __________________________________________________ 1 1.1 Important terms and concepts related to genomic imprinting __________________________ 2 1.2 CpG islands as regulatory elements ______________________________________________ 3 1.3 Differentially methylated regions and imprinting clusters_____________________________ 6 1.4 Reading the imprint __________________________________________________________ 8 1.5 Chromatin marks at imprinted regions___________________________________________ 10 1.6 Roles of repetitive elements ___________________________________________________ 12 1.7 Functional implications of imprinted genes _______________________________________ 14 1.8 Evolution and parental conflict ________________________________________________ -
134 Mb (Almost the Same As the Size of Chromosome 10). It Is ~4–4.5% of the Total Human Genome
Chromosome 11 ©Chromosome Disorder Outreach Inc. (CDO) Technical genetic content provided by Dr. Iosif Lurie, M.D. Ph.D Medical Geneticist and CDO Medical Consultant/Advisor. Ideogram courtesy of the University of Washington Department of Pathology: ©1994 David Adler.hum_11.gif Introduction The genetic size of chromosome 11 is ~134 Mb (almost the same as the size of chromosome 10). It is ~4–4.5% of the total human genome. The length of its short arm is ~50 Mb; the length of its long arm in ~84 Mb. Chromosome 11 is a very gene–rich area. It contains ~1,500 genes. Mutations of ~200 of these genes are known to cause birth defects or some functional abnormalities. The short arm of chromosome 11 contains a region which is known to be imprinted. As a result duplications of this region will have different manifestations depending on the sex of the parent responsible for this defect. Phenotypes of persons with duplications of the maternal origin will be different from the phenotypes of the persons with a paternal duplication of the same area. There are ~1,400 patients with different structural abnormalities of chromosome 11 as the only abnormality or in association with abnormalities for other chromosomes. At least 800 of these patients had different deletions of chromosome 11. Deletions of the short arm have been reported in ~250 patients (including those with an additional imbalance); deletions of the long arm have been described in ~550 patients. There are two syndromes caused by deletions of the short arm (both of these syndromes have been known for several years) and one well–known syndrome caused by distal deletions of the long arm (Jacobsen syndrome). -
WNT16 Is a New Marker of Senescence
Table S1. A. Complete list of 177 genes overexpressed in replicative senescence Value Gene Description UniGene RefSeq 2.440 WNT16 wingless-type MMTV integration site family, member 16 (WNT16), transcript variant 2, mRNA. Hs.272375 NM_016087 2.355 MMP10 matrix metallopeptidase 10 (stromelysin 2) (MMP10), mRNA. Hs.2258 NM_002425 2.344 MMP3 matrix metallopeptidase 3 (stromelysin 1, progelatinase) (MMP3), mRNA. Hs.375129 NM_002422 2.300 HIST1H2AC Histone cluster 1, H2ac Hs.484950 2.134 CLDN1 claudin 1 (CLDN1), mRNA. Hs.439060 NM_021101 2.119 TSPAN13 tetraspanin 13 (TSPAN13), mRNA. Hs.364544 NM_014399 2.112 HIST2H2BE histone cluster 2, H2be (HIST2H2BE), mRNA. Hs.2178 NM_003528 2.070 HIST2H2BE histone cluster 2, H2be (HIST2H2BE), mRNA. Hs.2178 NM_003528 2.026 DCBLD2 discoidin, CUB and LCCL domain containing 2 (DCBLD2), mRNA. Hs.203691 NM_080927 2.007 SERPINB2 serpin peptidase inhibitor, clade B (ovalbumin), member 2 (SERPINB2), mRNA. Hs.594481 NM_002575 2.004 HIST2H2BE histone cluster 2, H2be (HIST2H2BE), mRNA. Hs.2178 NM_003528 1.989 OBFC2A Oligonucleotide/oligosaccharide-binding fold containing 2A Hs.591610 1.962 HIST2H2BE histone cluster 2, H2be (HIST2H2BE), mRNA. Hs.2178 NM_003528 1.947 PLCB4 phospholipase C, beta 4 (PLCB4), transcript variant 2, mRNA. Hs.472101 NM_182797 1.934 PLCB4 phospholipase C, beta 4 (PLCB4), transcript variant 1, mRNA. Hs.472101 NM_000933 1.933 KRTAP1-5 keratin associated protein 1-5 (KRTAP1-5), mRNA. Hs.534499 NM_031957 1.894 HIST2H2BE histone cluster 2, H2be (HIST2H2BE), mRNA. Hs.2178 NM_003528 1.884 CYTL1 cytokine-like 1 (CYTL1), mRNA. Hs.13872 NM_018659 tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain (TNFRSF10D), 1.848 TNFRSF10D Hs.213467 NM_003840 mRNA. -
Gene Mapping of Familial Autosomal Dominant Dilated Cardiomyopathy to Chromosome 10Q21-23
Gene mapping of familial autosomal dominant dilated cardiomyopathy to chromosome 10q21-23. K R Bowles, … , R Pignatelli, J A Towbin J Clin Invest. 1996;98(6):1355-1360. https://doi.org/10.1172/JCI118922. Research Article Dilated cardiomyopathy (DCM) is the most common form of primary myocardial disorder, accounting for 60% of all cardiomyopathies. In 20-30% of cases, familial inheritance can be demonstrated; an autosomal dominant transmission is the usual type of inheritance pattern identified. Previously, genetic heterogeneity was demonstrated in familial autosomal dominant dilated cardiomyopathy (FDCM). Gene localization to chromosome 1 (1p1-1q1 and 1q32), chromosome 3 (3p25-3p22), and chromosome 9 (9q13-9q22) has recently been identified. We report one family with 26 members (12 affected) with familial autosomal dominant dilated cardiomyopathy in which linkage to chromosome 10 at the 10q21-q23 locus is identified. Using short tandem repeat polymorphism (STR) markers with heterozygosity > 70%, 169 markers (50% of the genome) were used before linkage was found to markers D10S605 and D10S201 with a pairwise LOD score = 3.91, theta = 0, penetrance = 100% for both markers. Linkage to 1p1-1q1, 1q32, 3p25-3p22, and 9q13-9q22 was excluded. We conclude that a new locus for pure autosomal dominant FDCM exists, and that this gene is localized to a 9 cM region of 10q21-10q23. The search for the disease causing gene and the responsible mutation(s) is ongoing. Find the latest version: https://jci.me/118922/pdf Gene Mapping of Familial Autosomal Dominant Dilated Cardiomyopathy to Chromosome 10q21-23 Karla R. Bowles,* Robert Gajarski,‡ Patrick Porter,‡ Veronica Goytia,‡ Linda Bachinski,ʈ Robert Roberts,ʈ Ricardo Pignatelli,‡ and Jeffrey A. -
Chromosome 10
Chromosome 10 Description Humans normally have 46 chromosomes in each cell, divided into 23 pairs. Two copies of chromosome 10, one copy inherited from each parent, form one of the pairs. Chromosome 10 spans more than 133 million DNA building blocks (base pairs) and represents between 4 and 4.5 percent of the total DNA in cells. Identifying genes on each chromosome is an active area of genetic research. Because researchers use different approaches to predict the number of genes on each chromosome, the estimated number of genes varies. Chromosome 10 likely contains 700 to 800 genes that provide instructions for making proteins. These proteins perform a variety of different roles in the body. Health Conditions Related to Chromosomal Changes The following chromosomal conditions are associated with changes in the structure or number of copies of chromosome 10. 10q26 deletion syndrome 10q26 deletion syndrome is a condition that results from the loss (deletion) of a small piece of chromosome 10 in each cell. The deletion occurs on the long (q) arm of the chromosome at a position designated 10q26. The signs and symptoms of 10q26 deletion syndrome vary widely, even among affected members of the same family. Affected individuals may have distinctive facial features, growth problems, mild to moderate intellectual disability, developmental delay, genital abnormalities in males, or skeletal or heart defects. People with 10q26 deletion syndrome are missing between 3.5 million and 17 million DNA building blocks (base pairs), also written as 3.5 and 17 megabases (Mb), at position q26 on chromosome 10. The exact size of the deletion varies, and it is unclear what exact region needs to be deleted to cause the condition. -
Stage-Specific Gene Expression Is a Fundamental Characteristic of Rat Spermatogenic Cells and Sertoli Cells
Stage-specific gene expression is a fundamental characteristic of rat spermatogenic cells and Sertoli cells Daniel S. Johnston*, William W. Wright†‡, Paul DiCandeloro*§, Ewa Wilson¶, Gregory S. Kopf*ʈ, and Scott A. Jelinsky¶ *Contraception, Women’s Health and Musculoskeletal Biology, Wyeth Research, 500 Arcola Road, Collegeville, PA 19426; †Division of Reproductive Biology, Department of Biochemistry and Molecular Biology, The Johns Hopkins Bloomberg School of Public Health, 615 North Wolfe Street, Baltimore, MD 21205- 2179; and ¶Biological Technologies, Biological Research, Wyeth Research, 87 Cambridge Park Drive, Cambridge, MA 02140 Edited by Ryuzo Yanagimachi, University of Hawaii, Honolulu, HI, and approved April 1, 2008 (received for review October 17, 2007) Mammalian spermatogenesis is a complex biological process that study detected 16,971 probe sets,** and analysis of their cell type occurs within a highly organized tissue, the seminiferous epithelium. and stage-regulated expression supported the conclusion that cyclic The coordinated maturation of spermatogonia, spermatocytes, and gene expression is a widespread and, therefore, fundamental charac- spermatids suggests the existence of precise programs of gene teristic of both spermatogenic and Sertoli cells. These data predicted expression in these cells and in their neighboring somatic Sertoli cells. that important biological pathways and processes are regulated as The objective of this study was to identify the genes that execute specific cell types progress through the stages of the cycle. these programs. Rat seminiferous tubules at stages I, II–III, IV–V, VI, VIIa,b, VIIc,d, VIII, IX–XI, XII, and XIII–XIV of the cycle were isolated by Results and Discussion microdissection, whereas Sertoli cells, spermatogonia plus early sper- Characterization of the Testicular Transcriptome. -
Chromosome 10 Introduction the Genetic Length of Chromosome 10 Is ~135 Mb. It Is ~4–4.5% of the Whole Human Genome. the Long A
Chromosome 10 ©Chromosome Disorder Outreach Inc. (CDO) Technical genetic content provided by Dr. Iosif Lurie, M.D. Ph.D Medical Geneticist and CDO Medical Consultant/Advisor. Ideogram courtesy of the University of Washington Department of Pathology: ©1994 David Adler.hum_10.gif Introduction The genetic length of chromosome 10 is ~135 Mb. It is ~4–4.5% of the whole human genome. The long arm of this chromosome (90 Mb) is twice as large as the short arm (45 Mb). This chromosome has between 800 and 1,200 genes. Almost 15% of these genes are known to be related to the development of body organs or to cause other types of genetic abnormalities. Different forms of structural abnormalities of this chromosome are reported in ~1,400 patients (including the persons where abnormalities of chromosome 10 were associated with abnormalities of other chromosomes). Various forms of deletions were found in ~750–800 patients. The ratio between persons with deletions of the short arm (~200) and the persons with deletions of the long arm (~550– 600) is close to the ratio between the genetic size of the short and long arms. There are two syndromes caused by deletions of the short arm (Di George syndrome type II and HDR syndrome) and several syndromes caused by deletions of the long arm. Two of these syndromes, which have small deletions of the proximal part of 10q and are associated with Hirschsprung’s disease and Cockayne’s syndrome, became known only after the invention of molecular cytogenetics. Two other syndromes (deletion 10q23 and distal deletions of 10q) have been well known for a long time. -
Partial Monosomy of Chromosome 10 Short Arms
J Med Genet: first published as 10.1136/jmg.20.2.107 on 1 April 1983. Downloaded from Journal of Medical Genetics, 1983, 20, 107-111 Partial monosomy of chromosome 10 short arms A GENCIK*, U BRONNIMANt, R TOBLERt, AND P AUJF DER MAUR* From *Zytogenetisches Labor, Pathologisches Institut der Universitdt, Bern; and tSduglingsspital Elfenau, Bern, Switzerland. SUMMARY Two children with monosmy IOp13 are reported. In the first case the monosomy was the result of a maternal balanced translocation t(3;10) (p27;pl3) while the second case was a de novo mutation. We reviewed clinical details of cases reported so far and found that certain symptoms are typical of the deletion of a comparatively large segment of chromosome 10 short arms. These symptoms include mental and growth retardation, skull abnormalities, antimongoloid slant of the eyes, ear abnormalities, anteverted nostrils, abnormalities of the hands and feet, cryptorchidism in boys, and, primarily, hypoplasia or aplasia of the olfactory bulbs and olfactory tracts as well as narrow palpebral fissures or eyelid ptosis. Since the first description by Elliott et al1 of a Family A probable partial deletion of lOp in a child with many clinical symptoms, a number of reports of patients II 1 12 with lOp partial monosomy have been published,2-7 copyright. thus enlarging the clinical picture. Deletion of part of the chromosome 10 short arms associated with deletion of the long arm terminal segment is also found in cases with ring chromosome 1 2 3 4 5 6 7 8 9 10 11 12 13 10.8-12 As a rule, the deletion of both telomeric Farmily B W Congenital anomalies segments is small and the clinical picture is not as I E} 4 ETranslocation carrier severe as in cases of the above mentioned iOp partial 1 2 E1Normal karyotype http://jmg.bmj.com/ monosomy. -
Chromosome 10 Abnormality Predicts Prognosis of Neuroblastoma Patients with Bone Marrow Metastasis
Jiang et al. Italian Journal of Pediatrics (2021) 47:134 https://doi.org/10.1186/s13052-021-01085-6 RESEARCH Open Access Chromosome 10 abnormality predicts prognosis of neuroblastoma patients with bone marrow metastasis Chi-yi Jiang1, Xiao Xu1, Bing-lin Jian1, Xue Zhang1, Zhi-xia Yue1, Wei Guo2 and Xiao-li Ma1* Abstract Background: Neuroblastoma (NB) is the most common extracranial solid tumor in children. It is known for high heterogeneity and concealed onset. In recent years, the mechanism of its occurrence and development has been gradually revealed. The purpose of this study is to summarize the clinical characteristics of children with NB and abnormal chromosome 10, and to investigate the relationship between the number and structure of chromosome 10 abnormalities and NB prognosis. Methods: Chromosome G-banding was used at the time of diagnosis to evaluate the genetics of chromosomes in patients with NB and track their clinical characteristics and prognosis. All participants were diagnosed with NB in the Medical Oncology Department of the Beijing Children’s Hospital from May 2015 to December 2018 and were followed up with for at least 1 year. Results: Of all 150 patients with bone marrow metastases, 42 were clearly diagnosed with chromosomal abnormalities. Thirteen patients showed abnormalities in chromosome 10, and chromosome 10 was the most commonly missing chromosome. These 13 patients had higher LDH and lower OS and EFS than children with chromosomal abnormalities who did not have an abnormality in chromosome 10. Eight patients had both MYCN amplification and 1p36 deletion. Two patients had optic nerve damage and no vision, and one patient had left supraorbital metastases 5 months after treatment. -
Terminal Deletion of the Long Arm of Chromosome 10 on September 30, 2021 by Guest
J Med Genet: first published as 10.1136/jmg.23.5.478 on 1 October 1986. Downloaded from 478 Case reports using routine methods and analysed after trypsin G abnormalities in balanced X;autosome trans- banding. In addition, lymphocytes were cultured locations, due to dissociation of genes from regulator with BrdU in order to demonstrate the late repli- sites or the spread of inactivation from an area of cating X chromosome. heterochromatin to a portion of the neighbouring Both parents had normal karyotypes, but the translocated chromosome which would not normally proband's karyotype revealed an apparently be inactivated. balanced X;13 translocation: 46,X,t(X;13) (Xpter-- Five of seven previously reported patients with X; Xql3: :13pll->13pter;13qter--13pll: :Xql3--Xqter) autosome translocations with breakpoints at Xq132 (figure). BrdU incorporation showed the normal X to were infertile, but none had other dysmorphic be late labelling in all of 100 cells examined. As the features. Of seven patients reported with deletions of normal X was late replicating in each cell, it was not Xq with breakpoints at Xql3, none had phenotypic possible to detect any spread of inactivation from the abnormalities other than the Turner stigmata.5 Our X to the 13 in the 100 cells examined. patient is thus the first reported case of a balanced X; autosome'translocation with a breakpoint at Xql3 and an abnormal phenotype, other than gonadal Discussion dysgenesis. Although it is easy to see why unbalanced X; autosome translocations cause phenotypic abnorma- References lities due to deletion or duplication of chromosomal Scheres JMJC, Merkx GFM, Hustinx TWJ.